029-83533393
   info@TaiBSbio.com
 
组织芯片，组织微阵列
多器官
头颈部
口腔
软组织(肌肉脂肪血管等)
皮肤
黑色素瘤
淋巴瘤
脑
心脏
鼻咽和喉
肺
骨和软骨
骨髓
食道
胃
小肠
结肠
直肠
肝
胰腺
阑尾
肾脏
尿道膀胱
甲状腺
肾上腺
胸腺
淋巴结
脾
乳腺
卵巢
输卵管
子宫及内膜
子宫颈
外阴 (阴唇)
前列腺
睾丸
阴茎
间皮
转移癌
胚胎瘤
胎儿
寄生虫
猴子 -恒河猴
猴子 -食蟹猴,
狗
大鼠
小鼠
其它
免疫系统
 
FOV8010不同分期的卵巢癌组织组合芯片（WHO+1999版），含转移癌，附病理分级、TNM和临床分期，80例/80点
点 数80例 数80
行 数8列 数10
点直径(mm)1.5厚度(µm)5.0
组织阵列类型石蜡包埋种 属人类
QA/QCH&E and IHC confirmed
ApplicationsRoutine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page.
Notes1.Please keep the slides at 4 ℃ after receiving, and make experiment within 3 months will be better.

2.Bake the slides for 30 minutes at 60℃ before the experiment;

3.Please choose a gentle repair method to avoid tissue detachment.
产品名:FOV8010
 
不同分期的卵巢癌组织组合微阵列芯片，包含浆液性腺腺癌60例，粘液性腺癌7例，子宫内膜样癌4例，腺癌和透明细胞癌各1例，移行细胞癌2例，转移癌5例，其中早期1例，中期38例，晚期36例，一例一点
 
 
询价  Tel: 029-83533393
 
下载说明书
 
 
Legend:
Lym
-Lymph node
Ova
-Ovary
 
Malignant (I)
 
Malignant (II)
 
Malignant (IIA)
 
Malignant (IIB)
 
Malignant (IIC)
 
Malignant (III)
 
Malignant (IIIC)
 
Malignant (IV)
 
Metastasis (*)
TISSUE  ARRAYS FOV8010
1
2
3
4
5
6
7
8
9
10
A
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
B
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
C
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
D
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
E
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
F
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
G
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
OVA
H
OVA
OVA
OVA
OVA
OVA
LYM
LYM
LYM
LYM
LYM
 
PosNoAgeSexOrgan_Anatomic_SitePathology_diagnosisGradeTNMStageTypeisBackUp
A1169FOvarySerous papillary adenocarcinoma1T2bN0M0IIBMalignantN
A2273FOvarySerous papillary adenocarcinoma2T2aN0M0IIAMalignantN
A3360FOvarySerous papillary adenocarcinoma2T2aN0M0IIAMalignantN
A4456FOvarySerous papillary adenocarcinoma2T2N0M0IIMalignantN
A5535FOvarySerous papillary adenocarcinoma2T2N0M0IIMalignantN
A6649FOvarySerous papillary adenocarcinoma2T2cN0M0IICMalignantN
A7763FOvarySerous papillary adenocarcinoma2T2bN0M0IIBMalignantN
A8849FOvarySerous papillary adenocarcinoma2T2N0M0IIMalignantN
A9960FOvarySerous papillary adenocarcinoma2T2bN0M0IIBMalignantN
A101045FOvarySerous papillary adenocarcinoma2T2N0M0IIMalignantN
B11151FOvarySerous papillary adenocarcinoma2T2aN0M0IIAMalignantN
B21265FOvarySerous papillary adenocarcinoma2T2N0M0IIMalignantN
B31356FOvarySerous papillary adenocarcinoma2T2N0M0IIMalignantN
B41441FOvarySerous adenocarcinoma3T2cN0M0IICMalignantN
B51556FOvarySerous adenocarcinoma3T2N0M0IIMalignantN
B61639FOvarySerous adenocarcinoma with necrosis3T2N0M0IIMalignantN
B71748FOvarySerous adenocarcinoma3T2aN0M0IIAMalignantN
B81875FOvarySerous adenocarcinoma3T2N0M0IIMalignantN
B91943FOvarySerous adenocarcinoma3T2N0M0IIMalignantN
B102051FOvarySerous adenocarcinoma3T2aN0M0IIAMalignantN
C12145FOvarySerous adenocarcinoma3T2bN0M0IIBMalignantN
C22259FOvarySerous adenocarcinoma3T2N0M0IIMalignantN
C32348FOvarySerous adenocarcinoma3T2bN0M0IIBMalignantN
C42441FOvaryMucinous adenocarcinoma2T2aN0MOIIAMalignantN
C52540FOvaryMucinous papillary adenocarcinoma2T2N0M0IIMalignantN
C62662FOvarySerous adenocarcinoma2T2aN0M0IIAMalignantN
C72750FOvaryMucinous adenocarcinoma3T2N0M0IIMalignantN
C82841FOvaryMucinous adenocarcinoma3T2aN0M0IIAMalignantN
C92960FOvaryEndometrioid adenocarcinoma with necrosis (sparse)*T2N0M0IIMalignantN
C103050FOvaryEndometrioid adenocarcinoma2T2aN0M0IIAMalignantN
D13168FOvaryEndometrioid adenocarcinoma3T2cN0M0IICMalignantN
D23229FOvaryAdenocarcinoma3T2aN0M0IIAMalignantN
D33347FOvaryMucinous adenocarcinoma3T2aN0M0IIAMalignantN
D43447FOvaryClear cell carcinoma*T2aN0M0IIAMalignantN
D53566FOvarySerous adenocarcinoma3T3N1M0IIICMalignantN
D63652FOvarySerous papillary adenocarcinoma2T3cN1M0IIICMalignantN
D73750FOvarySerous papillary adenocarcinoma2T3N1M0IIICMalignantN
D83854FOvarySerous papillary adenocarcinoma2T3cN1M0IIICMalignantN
D93951FOvarySerous papillary adenocarcinoma2T3N1M0IIICMalignantN
D104058FOvarySerous papillary adenocarcinoma2T2bN0M0IIBMalignantN
E14148FOvarySerous adenocarcinoma3T3cN0M0IIICMalignantN
E24238FOvarySerous adenocarcinoma3T1bN1M0IIICMalignantN
E34357FOvarySerous adenocarcinoma3T3cN1M0IIICMalignantN
E44453FOvarySerous adenocarcinoma3T3bN1M0IIICMalignantN
E54562FOvarySerous adenocarcinoma3T3N0M0IIIMalignantN
E64649FOvarySerous adenocarcinoma3T3N1M0IIICMalignantN
E74765FOvarySerous adenocarcinoma3T3cN0M0IIICMalignantN
E84847FOvarySerous adenocarcinoma3T3cN1M0IIICMalignantN
E94942FOvarySerous adenocarcinoma3T3cN1M0IIICMalignantN
E105046FOvarySerous adenocarcinoma3T2cN1M0IIICMalignantN
F15156FOvarySerous adenocarcinoma3T3N1M0IIICMalignantN
F25256FOvarySerous adenocarcinoma3T2N1M0IIICMalignantN
F35342FOvarySerous adenocarcinoma3T1N1M0IIICMalignantN
F45432FOvarySerous adenocarcinoma3T3cN0M0IIICMalignantN
F55546FOvarySerous adenocarcinoma3T3aN1M0IIICMalignantN
F65626FOvarySerous adenocarcinoma3T3CN1M0IIICMalignantN
F75757FOvarySerous adenocarcinoma2T3cN1M0IIICMalignantN
F85843FOvaryMucinous papillary adenocarcinoma1T3cN1M0IIICMalignantN
F95948FOvaryMucinous adenocarcinoma3T3cN0M0IIICMalignantN
F106052FOvaryTransitional cell carcinoma3T2N1M0IIICMalignantN
G16155FOvaryTransitional cell carcinoma3T3cN0M0IIICMalignantN
G26266FOvarySerous papillary adenocarcinoma2T3N0M1IVMalignantN
G36369FOvarySerous papillary adenocarcinoma2T2N0M1IVMalignantN
G46437FOvarySerous papillary adenocarcinoma2T3N1M1IVMalignantN
G56565FOvarySerous papillary adenocarcinoma2T2aN0M0IIAMalignantN
G66654FOvarySerous papillary adenocarcinoma2T2aN0M0IIAMalignantN
G76755FOvarySerous papillary adenocarcinoma2T3cN1M0IIICMalignantN
G86856FOvarySerous papillary adenocarcinoma2T3cN0M0IIICMalignantN
G96956FOvarySerous papillary adenocarcinoma2T3cN1M1IVMalignantN
G107048FOvarySerous adenocarcinoma2T3cN0M0IIICMalignantN
H17143FOvarySerous adenocarcinoma3T2N0M1IVMalignantN
H27265FOvarySerous adenocarcinoma3T2N0M1IVMalignantN
H37341FOvarySerous adenocarcinoma3T2aN0M0IIAMalignantN
H47451FOvarySerous adenocarcinoma3T1N0M0IMalignantN
H57559FOvaryEndometrioid adenocarcinoma2--3T2N0M1IVMalignantN
H67659FLymph nodeMetastatic serous adenocarcinoma3**MetastasisN
H77753FLymph nodeMetastatic serous adenocarcinoma from omenta3**MetastasisN
H87855FLymph nodeMetastatic serous adenocarcinoma from omenta2**MetastasisN
H97947FLymph nodeMetastatic serous adenocarcinoma3**MetastasisN
H108054FLymph nodeMetastatic serous adenocarcinoma3**MetastasisN
Tissue Marker
 
 
西安泰博斯生物科技有限公司

 
联系我们
地址：陕西西安市灞桥区长乐东路2999号
电话：029-83533393, 17792711553,
电子邮箱：taibsbio@163.com
QQ:3144647811
微信号：13002913390
邮政编码：710075
关于我们
西安泰博斯生物科技有限公司主要经营组织芯片的研发、销售，加工定制和与组织芯片有关的生物技术服务项目。公司目前拥有专业的病理医生和技术研发团队，并且具有庞大的组织标本库。样本库中组织微阵列种类多，病理类型齐全，同时根据客户需求情况进行制作加工新的组织微阵列，尽量满足每一个客户的需求。公司一直秉承着“认真、严谨、负责”的工作态度，致力于为广大客户提供质量好的产品和优质的服务。

更多详情